Whole-heart radiation therapy for advanced heart failure
Part of Heart & circulation clinical trials.
This trial tests if a low dose of radiation to the whole heart can help people with very advanced heart failure. It is for people who have severe symptoms despite maximum medications and are not candidates for a heart pump or transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have end-stage heart failure with symptoms even when resting or with light activity (NYHA class 3 or 4)
- Your heart's pumping strength is very low (LVEF of 30% or less)
- A blood test shows a high level of NT-Pro-BNP (1500 pg/mL or more)
- You are already on the best available heart failure medications but still getting worse
- You are not eligible for a left ventricular assist device or heart transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-invasive light therapy (photobiomodulation) for people with advanced heart failure who cannot have a heart transplant. It aims to see if this gentle light treatment can improve your symptoms and quality of life.
This trial is testing a new way to use MRI scans to help people with heart failure who need a special pacemaker called a CRT device. It may help doctors better understand how to treat your heart condition.
This trial tests if a low dose of radiation to the heart can help people with advanced heart failure feel better and improve heart function. It is for patients whose heart failure is stable but severe, and who are already on the best medications.
This study tests a new radiation treatment for advanced heart failure. It aims to see if radiation can improve heart function and symptoms.
This trial tests whether very low doses of radiation can help people with chronic heart failure whose symptoms persist despite standard treatments. It aims to reduce inflammation in the heart and improve how well it pumps.
This trial tests a new way to plan radiation for cancers in the chest area (like lung, esophageal, or thymus cancers) that aims to protect the heart from high doses of radiation. It is for people who need daily radiation for at least three weeks and who are expected to live more than a year.
Hear when a new Heart Failure NYHA Class III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.